MedCity News
APRIL 27, 2025
EMS providers often treat patients without medical history, risking delays, errors, and guesswork. But new national data-sharing frameworks are starting to close that gap, bringing critical records to first responders in real time. The post Bringing Patient Data to the Frontlines: Why Interoperability Must Include EMS appeared first on MedCity News.
PharmaVoice
APRIL 29, 2025
U.S. health agencies are taking the fight to vaccine and mRNA research, which could have lasting repercussions on medical and scientific advancements.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
APRIL 28, 2025
Introduction Imagine standing at the edge of a revolution, where every tool you need to succeed is finally within reach. That’s precisely where pharmaceutical marketers find themselves today. Pharma marketing innovation is poised for an unprecedented surge in 2025, driven by new technologies, regulatory shifts, and evolving patient expectations.
European Pharmaceutical Review
APRIL 28, 2025
Over the next few years, there are virtually no aspects of pharmaceutical manufacturing processes that will not be changed by artificial intelligence (AI). By harnessing AIs capabilities to analyse complex datasets, identify subtle patterns and make precise predictions, biopharmaceutical manufacturers will be able to achieve unprecedented levels of process optimisation, quality assurance and operational efficiency.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
APRIL 27, 2025
Many of those who survive the loss, devastation, and displacement of an extreme climate event such as a flood, tornado, drought, or wildfire experience anxiety, depression, post-traumatic stress disorder (PTSD), and even suicidal thoughts. Similar mental illnesses are often found even when people are indirectly exposed to extreme climate events. The post The Silent Mental Health Crisis of Climate Change appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharma Marketing Network
APRIL 29, 2025
Introduction When was the last time a glossy pharma ad truly resonated with a patient living with chronic illness? In today’s healthcare marketing landscape, trust is the new currencyand real stories matter more than polished commercials. Thats why Influencer Marketing In Pharma is gaining momentum as a critical tool for reaching audiences in a more authentic, impactful way.
European Pharmaceutical Review
APRIL 29, 2025
The US Pharmacopeia (USP) has launched a selection of resources, including reference materials and standards, to support developers and manufacturers of AAV-based gene therapies. Alongside these resources, USP is publishing the proposed General Chapter <1067> AAV Best Practices for the Manufacture and Quality Control of Recombinant Adeno-Associated Virus (rAAV) Gene Therapy Products.
MedCity News
APRIL 29, 2025
For employers to offer effective, accessible and affordable value-based care for their employees, they must address these four components. The post How Employers Can Leverage Value-Based Care to Drive Retention and Improved Health Outcomes for Employees appeared first on MedCity News.
PharmaVoice
APRIL 28, 2025
After a 20% cut to the FDA’s workforce, biotechs and pharmas are bracing for delays. But the impacts won’t be consistent.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Pharma Marketing Network
APRIL 29, 2025
Introduction Is traditional advertising losing its edge in the pharmaceutical world? As the industry shifts toward data-driven strategies, the power of audience targeting continues to redefine how brands connect with healthcare professionals (HCPs) and patients. While print ads, radio spots, and mass media campaigns once dominated, the ability to reach the right person at the right time through digital channels has quickly taken the lead.
Scott Burrows
APRIL 29, 2025
In the high-stakes world of insurance and financial services, setbacks are part of the game. Whether its a lost client, a market downturn, or an unexpected regulatory shift, the ability to pivot and push forward is what separates top performers from the rest. As someone who has faced life-altering challengesparalysis from a car accident at 19, a second accident that disrupted a thriving career, and the leap into uncharted territory in a new industryIve learned that resilience isnt just about bou
MedCity News
APRIL 29, 2025
[Sponsored] Sign up today and and join us on May 8th where we’ll explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies. The post Webinar: How Fintech Can Accelerate Growth for Early-Stage Life Science Companies appeared first on MedCity News.
Referral MD
APRIL 28, 2025
Research shows that 93% of patients prefer to use technology when communicating with medical practices. Yet, 61% of health insurance claims are denied due to errors originating in patient intake forms. This disconnect highlights a critical gap in healthcare administrationone that modern intake and scheduling solutions are well-positioned to address.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharma Marketing Network
APRIL 27, 2025
Introduction In todays hyper-competitive healthcare space, building a Lead Generation Network in pharma is no longer optionalits essential. Much like a clinical trial needs carefully selected participants, pharma marketers must construct targeted networks to generate high-quality leads. But how does one translate an abstract marketing concept into a practical strategy that complies with strict regulatory frameworks while producing measurable outcomes?
Contrarian Sales Techniques
APRIL 27, 2025
April 28, 2025 9:12 AM, hospital cafeteria. Just finished my second coffee. I don't know why it hit me today maybe it was the way Dr. Liew smiled and said, "I always remember you because you explain things clearly, not just push products." It got me thinking: personal branding for medical sales reps isnt just a nice-to-have anymore. Its the whole game.
MedCity News
APRIL 29, 2025
Abeona Therapeutics makes Zevaskyn by engineering a patients biopsied skin cells to express the collagen that they lack, then growing those cells into sheets that can be surgically applied to a wound. Abeona’s cell-based gene therapy is just the third FDA-approved treatment for epidermolysis bullosa, a rare disease that leads to skin described as thin and fragile like a butterflys wings.
pharmaphorum
APRIL 28, 2025
The New England Journal of Medicine (NEJM) has hit back at assertions of bias in its editorial policies from Republican activist Edward Martin Jr
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PM360
APRIL 28, 2025
April 15, 2025, New York, NY Inizio Evoke, a leading global health marketing, communications, and transformation platform, announced today the appointment of Tristen George and Kevin Kaniuga to the role of Executive Creative Director, further strengthening the agencys creative leadership as it continues to evolve its offering and elevate the standard of omnichannel engagement for health brands.
Pharmaceutical Technology
APRIL 28, 2025
Amgen has announced a significant expansion of the Ohio manufacturing facility in the US, with an investment of $900m.
MedCity News
APRIL 27, 2025
A federal court judge ruling leaves in place an FDA determination that shortages of the Novo Nordisk drugs Wegovy and Ozempic are resolved. Consequently, compounding pharmacies must stop making their versions of the metabolic medicines or face FDA enforcement action. The post Novo Nordisk Notches a Court Win Against Wegovy and Ozempic Compounders appeared first on MedCity News.
pharmaphorum
APRIL 28, 2025
Italfarmaco's oral HDAC inhibitor Duvyzat has been recommended for approval in the EU as a treatment for Duchenne muscular dystrophy (DMD)
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
PharmaTech
APRIL 29, 2025
Pharmaceutical Technology spoke with Alexander Seyf, CEO and co-founder of Autolomous, about how the political landscape may impact the pharmaceutical industry.
Pharmaceutical Technology
APRIL 29, 2025
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for BridgeBio Pharmas acoramidis.
MedCity News
APRIL 28, 2025
The status quo for medical malpractice insurance is no longer good enough. While we must always prioritize the need for accountability when it comes to medical malpractice, we must also consider how challenges like increased premiums, rising costs and new risks are impacting providers and consequentially patients. The post Its Time for Medical Malpractice Insurance to Emerge from the Stone Age appeared first on MedCity News.
pharmaphorum
APRIL 29, 2025
Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmacy Times
APRIL 28, 2025
Panelists discuss how statin therapy for primary prevention requires careful consideration of cardiovascular risk factors against potential adverse effects such as myalgia and liver abnormalities, generally favoring treatment when the calculated 10-year atherosclerotic cardiovascular disease [ASCVD] risk exceeds 7.5% to10% and adjusting recommendations based on individual patient factors including age, comorbidities, and preferences.
Pharmaceutical Technology
APRIL 28, 2025
The FDA has granted rare paediatric disease and orphan drug designations for IN013, Innorna's mRNA therapeutic for Wilson's disease.
MedCity News
APRIL 28, 2025
SpringWorks Therapeutics brings to Merck KGaA two FDA-approved drugs, both currently under regulatory review in Europe. Beyond their initial applications in rare tumors, these small molecules are also being studied as monotherapies and as part of combinations treatments for certain cancers. The post Merck KGaAs Rare Tumor Strategy Takes Shape With $3.9B SpringWorks Acquisition appeared first on MedCity News.
Expert insights. Personalized for you.
226 
Let's personalize your content